US delays small imports rule that raised alarm over prescription drug costs

The US has delayed the implementation of a small imports rule that previously raised alarms regarding the cost of prescription drugs. This strategic move is intended to prevent higher prices for imported prescription drugs and various other products for inflation-weary Americans. By postponing the rule, the government ensures that these potential price increases do not take effect until after the November midterm elections, providing temporary financial relief to consumers during a period of high inflation.